BioXcel Therapeutics Inc KOL Virtual Roundtable Day Transcript
Greetings and welcome to the BioXcel Therapeutics KOL virtual roundtable day. At this time, participants are in listen-only mode. You can submit your questions by typing them in the ask a Question field on the bottom of your screen. It is now my pleasure to introduce Vimal Mehta, CEO. Thank you. You may begin.
Thank you, operator. Good afternoon, everyone, and thank you for joining us today. I would like to start by welcoming our participants. We are thankful for your leadership and expertise in the Alzheimer's agitation space, particularly as we focus on the significant and under-addressed challenge of acute agitation episodes in Alzheimer's dementia.
Next, I would like to thank our moderator, Anjalee Khemlani, an award-winning journalist who moderated our last panel in December. We are thankful to have our experienced voice be the guide for today's conversation among our distinguished guests. There are currently no FDA approved treatments specifically for acute
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
